Related content

Agomelatine for the treatment of major depressive disorder

By Carney Regina M   Shelton Richard C  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 327-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relative short‐term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 33, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder

By Frampton James E.   Plosker Greg L.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite